(Q84708142)

English

Prognostic Impact of Myocardial Interstitial Fibrosis in Non-Ischemic Heart Failure - Comparison Between Preserved and Reduced Ejection Fraction Heart Failure -

scientific article published on 06 August 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21821961%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Prognostic Impact of Myocardial Interstitial Fibrosis in Non-Ischemic Heart Failure - Comparison Between Preserved and Reduced Ejection Fraction Heart Failure - (English)

reason for preferred rank

most precise value

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Prognostic impact of myocardial interstitial fibrosis in non-ischemic heart failure. -Comparison between preserved and reduced ejection fraction heart failure.- (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21821961

9 December 2024

1 reference

based on heuristic

inferred from title

ejection fraction

1 reference

based on heuristic

inferred from title

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21821961

9 December 2024

Hiroaki Shimokawa

8

object named as

Hiroaki Shimokawa

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21821961

9 December 2024

author name string

Tatsuo Aoki

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21821961%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Yoshihiro Fukumoto

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21821961%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Koichiro Sugimura

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21821961%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Minako Oikawa

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21821961%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Kimio Satoh

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21821961%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Makoto Nakano

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21821961%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Masaharu Nakayama

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21821961%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21821961

9 December 2024

publication date

6 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21821961%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Circulation Journal

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21821961%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

75

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21821961%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21821961%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

2605-2613

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21821961%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

The role of myocardial fibrillar collagen in ventricular remodeling and function

1

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Genetically determined resistance to collagenase action augments interstitial collagen accumulation in atherosclerotic plaques.

2

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Cardiomyocyte Stiffness in Diastolic Heart Failure

3

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients

4

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Diastolic Stiffness of the Failing Diabetic Heart

5

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms

6

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Spatial disruption and enhanced degradation of collagen with the transition from compensated ventricular hypertrophy to symptomatic congestive heart failure

7

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Infarct morphology identifies patients with substrate for sustained ventricular tachycardia

8

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy

9

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Assessment of nonischemic myocardial fibrosis

10

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure

11

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Independent and additional prognostic value of aminoterminal propeptide of type III procollagen circulating levels in patients with chronic heart failure.

12

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Biomarkers in heart failure

13

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Urinary and serum type II collagen: markers of renal fibrosis

14

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Other non-invasive markers of liver fibrosis

15

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Myocardial Structure and Function Differ in Systolic and Diastolic Heart Failure

16

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Long-term inhibition of Rho-kinase ameliorates diastolic heart failure in hypertensive rats

17

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study

18

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Heart failure with preserved systolic function. A different natural history?

19

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Long term prognosis of chronic heart failure: reduced vs preserved left ventricular ejection fraction

20

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD).

21

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Trends in prevalence and outcome of heart failure with preserved ejection fraction

22

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Cost/utility ratio in chronic heart failure: comparison between heart failure management program delivered by day-hospital and usual care

23

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Alterations in the pattern of collagen deposition may contribute to the deterioration of systolic function in hypertensive patients with heart failure

24

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Elevated serum markers of collagen degradation in patients with mild to moderate dilated cardiomyopathy

25

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Cytokines, interstitial collagen and ventricular remodelling in dilated cardiomyopathy

26

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Dilated cardiomyopathy is associated with an increase in the type I/type III collagen ratio: a quantitative assessment

27

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Gadolinium Cardiovascular Magnetic Resonance Predicts Reversible Myocardial Dysfunction and Remodeling in Patients With Heart Failure Undergoing β-Blocker Therapy

28

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping

29

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Comparative evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance

30

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Electrocardiography and Doppler echocardiography for risk stratification in patients with chronic heart failure: incremental prognostic value of QRS duration and a restrictive mitral filling pattern

31

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Pseudonormal mitral filling pattern predicts hospital re-admission in patients with congestive heart failure

32

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

33

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study

34

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease

35

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Effects of ACE inhibition versus non-ACE inhibitor antihypertensive treatment on myocardial fibrosis in patients with arterial hypertension. Retrospective analysis of 120 patients with left ventricular endomyocardial biopsies

36

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial

37

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

38

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

A randomized double-blind trial of enalapril in older patients with heart failure and preserved ejection fraction: effects on exercise tolerance and arterial distensibility.

39

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

A randomized, double-blind, placebo-controlled study to determine the effects of valsartan on exercise time in patients with symptomatic heart failure with preserved ejection fraction.

40

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Progression of preserved systolic function heart failure to systolic dysfunction -- a natural history study

41

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

What mechanisms underlie diastolic dysfunction in heart failure?

42

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Cross-linking influences the impact of quantitative changes in myocardial collagen on cardiac stiffness and remodelling in hypertension in rats.

43

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Reduction in myocardial collagen cross-linking parallels left ventricular dilatation in rat models of systolic chamber dysfunction

44

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Biochemical assessment of myocardial fibrosis in hypertensive heart disease

45

1 reference

10.1253/CIRCJ.CJ-11-0568

https://api.crossref.org/works/10.1253/CIRCJ.CJ-11-0568

9 December 2024

Identifiers

10.1253/CIRCJ.CJ-11-0568

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21821961%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21821961%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84708142&oldid=2285156937"